These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38289166)

  • 21. Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters.
    Bandara S; Kennedy-Hendricks A; Merritt S; Barry CL; Saloner B
    Addiction; 2021 Dec; 116(12):3473-3481. PubMed ID: 33999458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatment.
    Casati A; Piontek D; Pfeiffer-Gerschel T
    Subst Abuse Treat Prev Policy; 2014 May; 9():19. PubMed ID: 24885218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
    Zedler BK; Mann AL; Kim MM; Amick HR; Joyce AR; Murrelle EL; Jones HE
    Addiction; 2016 Dec; 111(12):2115-2128. PubMed ID: 27223595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome evaluation of the opioid agonist maintenance treatment in Iran.
    Esmaeili HR; Ziaddinni H; Nikravesh MR; Baneshi MR; Nakhaee N
    Drug Alcohol Rev; 2014 Mar; 33(2):186-93. PubMed ID: 24428135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
    Jones HE; Finnegan LP; Kaltenbach K
    Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
    Fingerhood MI; King VL; Brooner RK; Rastegar DA
    Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.
    Magura S; Lee JD; Hershberger J; Joseph H; Marsch L; Shropshire C; Rosenblum A
    Drug Alcohol Depend; 2009 Jan; 99(1-3):222-30. PubMed ID: 18930603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Underrepresentation of diverse populations and clinical characterization in opioid agonist treatment research: A systematic review of the neurocognitive effects of buprenorphine and methadone treatment.
    Mindt MR; Coulehan K; Aghvinian M; Scott TM; Olsen JP; Cunningham CO; Arias F; Arnsten JH
    J Subst Abuse Treat; 2022 Apr; 135():108644. PubMed ID: 34857427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.
    Nunn A; Zaller N; Dickman S; Trimbur C; Nijhawan A; Rich JD
    Drug Alcohol Depend; 2009 Nov; 105(1-2):83-8. PubMed ID: 19625142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance.
    Awgu E; Magura S; Rosenblum A
    J Psychoactive Drugs; 2010 Sep; 42(3):339-46. PubMed ID: 21053756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
    Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
    Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?
    Garcia-Portilla MP; Bobes-Bascaran MT; Bascaran MT; Saiz PA; Bobes J
    Br J Clin Pharmacol; 2014 Feb; 77(2):272-84. PubMed ID: 23145768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
    Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
    Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
    Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzodiazepine Use in Opioid Maintenance Treatment Programme: Risks and Clinical Outcomes.
    Oliveira C; Filipe R; Meira J; Sampaio L; Teixeira L; Rodrigues J; Nunes I; Tavares J
    Acta Med Port; 2021 Mar; 34(3):209-216. PubMed ID: 33971116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.